Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human CLN3 ELISA Kit (AC3299)
Cat.#: ASET-1888
Specifications
Description Human CLN3 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human CLN3 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.64 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 125-2000 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1214 Human Apo-D ELISA Kit (AC2625) Quantitative inquiry ASET-1252 Human Granuphilin ELISA Kit (AC2663) Quantitative inquiry ASET-2125 Mouse Heme Oxygenase 1 ELISA Kit (AC3536) Quantitative inquiry ASET-1667 Rat Vimentin ELISA Kit (AC3078) Quantitative inquiry ASET-1452 Mouse Cannabinoid Receptor II ELISA Kit (AC2863) Quantitative inquiry ASET-2299 Human FGF13 ELISA Kit (AC3710) Quantitative inquiry ASET-1133 Human Neuroglobin ELISA Kit (AC2544) Quantitative inquiry ASET-1216 Mouse VEGFC ELISA Kit (AC2627) Quantitative inquiry ASET-1386 Mouse NMDAR1 ELISA Kit (AC2797) Quantitative inquiry ASET-1285 Human Serotonin Transporter ELISA Kit (AC2696) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket